2020 / 01

Next Paper
DOI: 10.24075/brsmu.2020.011

ORIGINAL RESEARCH

Hereditary risk factors for uterine leiomyoma: a search for marker SNPs

Svirepova KA1, Kuznetsova MV1, Sogoyan NS1, Zelensky DV2, Lolomadze EA1, Mikhailovskaya GV1, Mishina ND1, Donnikov AE1, Trofimov DYu1
About authors

1 Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

2 Valuyki Central Hospital, Valuyki, Russia

Correspondence should be addressed: Ksenia A. Svirepova
Akademika Oparina, 4, Moscow, 117997; ur.xednay@iwsesk

About paper

Funding: this study was part of the State Assignment (2019) on the Improved management of patients with benign reproductive system neoplasms with hi-tech diagnostic imaging techniques and molecular panels for predicting the progression and relapse of the disease.

Compliance with ethical standards: the study was approved by the Ethics Committee of Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology. Informed consent was obtained from all participants.

Author contribution: Svirepova KA analyzed the literature, carried out the research and wrote the manuscript with input from all authors; Kuznetsova MV carried out the research and wrote the manuscript with input from all authors; Sogoyan NS collected tissue samples and documented them in the biobank’s register; Zelensky DV collected tissue samples for research; Lolomadze EA, Mikhailovskaya GV helped with the laboratory part of the research; Mishina ND performed statistical analysis; Donnikov AE, Trofimov DYu supervised the study and revised the manuscript.

Received: 2020-02-05 Accepted: 2020-02-19 Published online: 2020-02-29
|
  1. Adamyan LV, Andreeva EN, Artymuk NV, Belocerkovceva LD, Bezhenar VF, Gevorkyan MA, i dr. Mioma matki: diagnostika, lechenie i reabilitacija. 2015; 101. Russian.
  2. Adamyan LV, Spicyn VA, Andreeva EN. Geneticheskie akpekty ginekologicheskih zabolevanij. M., GJeOTAR-Media, 2008; 215. Russian.
  3. Sogoyan NS, Kuznetsova MV, Asaturova AV, Adamyan LV, Trofimov DYu. Somaticheskie mutacii v jekzone 2 gena MED12 u zhenshhin s odinochnoj i mnozhestvennoj miomoj matki. Akusherstvo i ginekologija. 2018; (12): 63–70. Russian.
  4. Sogoyan NS, Adamyan LV. Geneticheskie mehanizmy razvitija miomy matki. Problemy reprodukcii. 2016; 22 (1): 28–34. Russian.
  5. Kudrina EA, Baburin DV. Mioma matki: sovremennye aspekty patogeneza i lechenija (klinicheskaja lekcija). Arhiv akusherstva i ginekologii im. VF Snegireva. 2016; 3 (1): 4–10. Russian.
  6. Kuznetsova MV, Trofimov DYu, Tihonchuk EYu, Sogoyan NS, Adamyan LV, Suhih GT. Molekuljarnye mehanizmy patogeneza miomy matki: analiz mutacij gena MED12 v Rossijskoj populjacii. Akusherstvo i ginekologija. 2016; (10): 85–90. Russian.
  7. Sidorova IS. Mioma matki: vozmozhnosti lechenija i profilaktiki. Russkij medicinskij zhurnal. (Spec. nomer: Mat' i ditja.) 2002; 10 (7): 336–9. Russian.
  8. Barjon K, Mikhail LN. Uterine Leiomyomata (Fibroids). StatPearls Publishing, Treasure Island (FL) StatPearls. 2019; 15.
  9. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman, JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American journal of obstetrics and gynecology. 2003; 188 (1): 100–107.
  10. Gracia M, Carmona F. Uterine myomas: clinical impact and pathophysiological bases. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2020; (1): 1–5.
  11. Tihomirov AL. Patogeneticheskoe obosnovanie rannej diagnostiki, lechenija i profilaktiki miomy matki [dissertacija]. M., 1998. Russian.
  12. Tihomirov AL. Mioma, patogeneticheskoe obosnovanie organosohranjajushhego lechenija. M.: Medicina, 2013; 319. Russian.
  13. Brouwer MW, Tebbe-Gholami M, Starink MV. Hereditary leiomyomatosis: a woman with red-brown nodules. Nederlands tijdschrift voor geneeskunde. 2015; (159): A8867–A8867.
  14. Bulun SE. Uterine fibroids. New England Journal of Medicine. 2013; 369 (14): 1344–55.
  15. Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011; 334 (6053): 252–5.
  16. Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A. MED12 gain-of-function mutation causes leiomyomas and genomic instability.The Journal of clinical investigation. 2015; 125 (8): 3280–4.
  17. Akbari M, Do AA, Yassaee F, Mirfakhraie R. MED12 Exon 1 Mutational Screening in Iranian Patients with Uterine Leiomyoma. Reports of biochemistry & molecular biology. 2019; 8 (1): 1–21.
  18. Markowski DN, Bartnitzke S, Löning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations in uterine fibroids — their relationship to cytogenetic subgroups.International journal of cancer. 2012; 131 (7): 1528–36.
  19. Savickij GA, Savickij AG. Mioma matki (problemy patogeneza i patogeneticheskoj terapii). Novoe v akusherstve i ginekologii. Sankt-Peterburg: JeLBI, 2000; 236. Russian.
  20. Samojlova TE. Vozmozhnosti i perspektivy medikamentoznogo lechenija miomy matki. Medicinskij sovet. 2013; (3): 106–9. Russian.
  21. Pshenichnjuk EYu, Kuznecova MV, Burmenskaja OV, Kochetkova TO, Nepsha OS, Trofimov DYu, i dr. Associacija mezhdu chastotami vstrechaemosti odnonukleotidnyh polimorfizmov v genah ZNF366 i VEZT i riskom razvitija naruzhnogo genital'nogo jendometrioza: dannye po rossijskoj populjacii. Akusherstvo i ginekologija. 2017; (6): 64–73. Russian.
  22. Sakai K, Tanikawa C, Hirasawa A, Chiyoda T, Yamagami W, Kataoka F. Identification of a novel uterine leiomyoma GWAS locus in a Japanese population. Scientific Reports. 2020; 10 (1): 1–8.
  23. LaFleur B. Book Review: Statistical methods for rates and proportions. Clinical Trials. 2004; 1 ( 6): 567–8.
  24. Gallagher CS, Makinen N, Harris HR, Uimari O, Cook JP, Shigesi N, et al. Genome-wide association analysis identifies 27 novel loci associated with uterine leiomyomata revealing common genetic origins with endometriosis. Biorxiv. 2018; 1–26.
  25. Gallagher CS, Mäkinen N, Harris HR, RahmiogluN, UimariO, Cook JP, et al. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nature communications. 2019; 10 (1): 1–11.
  26. Cha PC, Takahashi A, Hosono N, Low SK, Kamatani N, Kubo M, et al. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nature genetics. 2011; 43 (5): 447.
  27. Sogoyan NS, Kuznetsova MV, Lolomadze EA, Mikhailovskaya GV, Mishina ND, Trofimov DYu, et al. A study of polymorphisms rs3020434, rs 1742635, rsl24577644, rsl2637801, rs2861221, and rs 17677069 in women with uterine leiomyomas and a family history of the disease. Obstetrics and Gynegology. 2019; (10): 115–28.